Drug Patents owned by J And J Consumer Inc
1. List of Pepcid Ac drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6814978
(Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(11 months ago) | |
Drugs and Companies using FAMOTIDINE ingredient
Market Authorisation Date: 24 September, 1998
Treatment: NA
Dosage: TABLET, CHEWABLE;ORAL
2. List of Pepcid Complete drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6814978
(Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(11 months ago) | |
Drugs and Companies using CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE ingredient
Market Authorisation Date: 16 October, 2000
Treatment: NA
Dosage: TABLET, CHEWABLE;ORAL
3. List of Zyrtec-d 12 Hour drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7226614 | J AND J CONSUMER INC | Tablet comprising cetirizine and pseudoephedrine |
Jun, 2022
(7 months ago) | |
| US7014867 | J AND J CONSUMER INC | Tablet comprising cetirizine and pseudoephedrine |
Jun, 2022
(7 months ago) | |
Drugs and Companies using CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE ingredient
Market Authorisation Date: 09 November, 2007
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, EXTENDED RELEASE;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic